PERSPECTIVE THERAPEUTICS, INC.

CATX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $48.5M $54.0M $30.6M $26.8M $28.8M $44.4M $61.6M $226.4M
Accounts Receivable $269.0K $58.0K $6.0K $179.0K $225.0K $78.0K $116.0K $217.0K
Inventory
Total Current Assets $241.5M $275.4M $148.4M $178.5M $196.0M $215.7M $231.2M $270.2M
Property, Plant & Equipment $107.8M $92.5M $76.6M $64.4M $62.6M $61.2M $57.3M $43.8M
Goodwill $0 $24.1M
Intangible Assets (Excl. Goodwill) $362.0K $279.0K
Total Assets $392.0M $410.8M $267.0M $294.8M $310.7M $329.3M $341.1M $391.2M
Liabilities
Accounts Payable
Total Current Liabilities $36.5M $31.5M $28.7M $20.6M $13.0M $12.7M $18.2M $28.1M
Long-Term Debt $1.6M $1.6M $1.6M $1.6M $1.7M $1.7M $1.7M $1.7M
Total Liabilities $68.2M $63.3M $59.9M $52.6M $45.0M $44.7M $50.4M $62.7M
Stockholders' Equity
Retained Earnings $-387.8M $-361.0M $-334.8M $-297.4M $-271.4M $-249.9M $-231.7M $-191.6M
Total Stockholders' Equity $323.9M $347.4M $207.0M $242.2M $265.7M $284.6M $290.7M $328.5M
← Newer Page 1 of 8 Older →